MENU
PHAR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pharming Group (PHAR) Ownership - Who owns Pharming Group?

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases... Show more

Profile

Industry
N/A
Address
Darwinweg 24
Phone
+31 715247400
Employees
332
Web
https://www.pharming.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.18B
P/E Ratio
N/A
Total Cash
166.17M
Projected Growth
N/A
Total Debt
130.92M
Revenue
362.27M
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash/Share
2.39
Total Debt/Equity
N/A
Revenue/Share
4.84 USD as % of share price

Fundamentals

PHAR
Capitalization
1.18B
P/E Ratio
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash
166M
Total Cash/Share
2.39
Total Debt
131M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.84%
Revenue
362M
ROE
N/A
Book Value
265M
P/B Ratio
4.76
Cash Flow
N/A
Earnings
0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.95M
Current Ratio
3.16
Current Revenue Per Employee
240809.40
Dividends Per Share - Security
N/A
EBITDA
44.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.73
Revenue To Assets
0.09
Shares Held By Institutions
919K
Shares Outstanding - Current
69.7M
Total Liabilities
209M
Total Volume MTD
N/A
Value
-1
Gain YTD
79.732
View a ticker or compare two or three
PHAR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHAR showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Darwinweg 24
Phone
+31 715247400
Employees
332
Web
https://www.pharming.com